Tumour-Only RNA-Seq to Predict Response to Immune Checkpoint Blockade in Patients With NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Predicting response to immune checkpoint blockade in NSCLC with tumour-only RNA-seq
Br. J. Cancer 2022 Dec 26;[EPub Ahead of Print], JF Markham, AP Fellowes, T Green, JL Leal, R Legaie, D Cullerne, T Morris, T John, B Solomon, SB FoxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.